{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilmington",
      "state": "MA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75490",
      "recalling_firm": "CutisPharma, Inc.",
      "address_1": "841 Woburn St",
      "address_2": "N/A",
      "postal_code": "01887-3414",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0139-2017",
      "product_description": "FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 3 OZ, Rx only,  Manufactured for CutisPharma Wilmington, MA,  NDC# 65628-070-03",
      "product_quantity": "5904 kits",
      "reason_for_recall": "Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL",
      "recall_initiation_date": "20161020",
      "center_classification_date": "20161116",
      "termination_date": "20170912",
      "report_date": "20161123",
      "code_info": "Lot #: E1396, Exp. 08/2018"
    }
  ]
}